Acamprosate or placebo: brain electrical activity during alcohol-use treatment
About this title
Read the official source — NCT06269627Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
What will I do during this study?
After a detoxification period of about seven days, participants stay in the clinic for 21 days. They are randomly assigned to acamprosate or placebo (an inactive comparison treatment), taken as two capsules three times a day. EEG (recording of the brain’s electrical activity) recordings and anxiety and craving assessments are completed before and after the treatment period.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 48
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT06269627
- Official title
Show the full official title
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
Recruitment & locations
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.
Does this study involve medication?
Yes. The study involves medication, including Acamprosate calcium.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
